Stanley Capital Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1M Buy
667,329
+44,000
+7% +$1.4M 2.53% 18
2026
Q1
$19.6M Hold
623,329
3.28% 11
2025
Q4
$18.4M Buy
623,329
+53,000
+9% +$1.47M 3.07% 12
2025
Q3
$14.4M Buy
570,329
+156,880
+38% +$3.82M 2.37% 22
2025
Q2
$9.92M Buy
413,449
+213,449
+107% +$4.95M 1.67% 27
2025
Q1
$4.58M Buy
+200,000
New +$4.83M 0.9% 35

Other funds holding RTO

Stanley Capital Management's RTO Position: Q2 2026 in Review

Stanley Capital Management increased its Rentokil (RTO) stake by 7.1% in Q2 2026, buying an estimated $1.4M and bringing the position to 667,329 shares worth $19.1M. The position accounts for 2.53% of the portfolio, ranked #18.

Stanley Capital Management first reported a position in RTO in Q1 2025 and has held it in 6 quarters since. The position peaked at $19.6M in Q1 2026. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Stanley Capital Management held 667,329 shares of Rentokil worth $19.1M as of Q2 2026.
  • Stanley Capital Management bought 44,000 Rentokil shares in Q2 2026, an estimated $1.4M.
  • Rentokil made up 2.53% of Stanley Capital Management's portfolio in Q2 2026, its #18 holding.
  • Stanley Capital Management first reported a position in Rentokil in Q1 2025 and has held it in 6 quarters since.
  • Stanley Capital Management's Rentokil position peaked at $19.6M in Q1 2026.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Stanley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.